AQEMIA is a French technology company that uses quantum-inspired algorithms and artificial intelligence for drug discovery. It develops therapeutic candidates and works with pharmaceutical and biotechnology companies to accelerate the design of new medicines.
Subscribe to see AQEMIA’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
AQEMIA is a deep tech company headquartered in France. Its most recent funding round, Series A, raised $38M in December 2024. Xcout tracks 1 named person at AQEMIA, including Maximilien Levesque (CEO and co-founder). Xcout recorded 1 job posting from AQEMIA in the last 90 days.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $38M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 1 job posting from AQEMIA in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see AQEMIA's hiring signals →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.